mygluco.com "now it's easier to take care of yourself"

"TeleHealth Meets Diabetes"

"The [Diabetes HouseCall] technology gives me the ability to reach into their homes and guide them. It's not as encumbering to my practice [vs. other technologies] and it makes it easier for me to check back on patients."

- Stephen Ponder, MD FAAP CDE

Diabetes Self Management Magazine is typically found on the table in the waiting room of your doctor's office. Read the entire article on page 15 of the current issue; July/August 2008.

The Diabetech® Universal Mobile Health Platform Connects Patients and Their Extended Teams for Advanced Diabetes Care Anywhere

Dallas, TX   July 16, 2008 – Diabetech today announced the availability of its highly personal and comprehensive health management device, the Diabetech® Universal Mobile Health Platform, a powerful tool for patients as well as the people who work with them. The UMHP brings diabetes management into the 21st Century (sometimes kicking and screaming) as it is only the second high-end computing platform to achieve certification in support of Diabetes HouseCall™, a new program that connects people with diabetes and their endocrinologists remotely while also equipping patients with advanced self-care tools.

“The Diabetech UMHP by itself is an advancement in computing. As part of Diabetes HouseCall, including remote connectivity to Diabetech's hosted ADMS™ (automated diabetes management system) and turn key support services, it revolutionizes the standard of care in diabetes.” says Stephen Ponder MD, CDE and the founding endocrinologist behind Diabetes HouseCall.

The UMHP offers an out of the box experience that is hard to find elsewhere. The UMHP is a powerful Linux based platform including a built-in mobile webcam for remote visits, a suite of applications for medical device connections, a productivity suite for word processing, spreadsheets, etc..., email, Internet, and remote data connectivity including transmission, analysis, reminders and report review. Finally, the UMHP includes a rich media experience for delivering diabetes related education and comes in a variety of custom colors.

Connectivity options include 3 USB2.0 ports for local vital sign device connectivity, built-in WiFi and an optional high-speed wireless bundle that includes a 3G network card and airtime. The optional 3G bundle solves the problem for patients and facilities where on premise connectivity including regular home telephones or broadband DSL/Cable are not readily available.

The UMHP is available for purchase or as a loaner including diabetes savvy technical support in the US market only. Contact the team at mygluco.com for inventory status, 3G coverage verification and pricing. While the time line for availability in the European market has not yet been finalized, the UMHP already carries the CE mark ensuring the UMHP is built with to the highest quality standards and easy access to this very important market.

“We believe the Diabetech UMHP represents the ultimate health management device. By leveraging the price/performance curve of a commercial IT platform, building in the relevant health care software and remote connectivity options and certifying it for use in the most advanced diabetes care model anywhere, the UMHP redefines the definition of what is a personal health system” stated Kevin McMahon, Diabetech's President & CEO.

For More Information
To learn more about the Diabetes HouseCall program and the UMHP, go to http://mygluco.com/diabeteshousecall. Diabetech can also be reached toll free at 877.My.Gluco or sales@diabetech.net.

About Diabetech
Diabetech is a company founded in 2002 with a charter to lead the world in the convergence of wireless and medical devices. Since then the Company has expanded its technology to support comprehensive patient-centric programs for the broad diabetes community. Diabetech's devices, diagnostic test kits and other tools for better health are available exclusively through its mygluco.com Internet community. Diabetech is a registered trademark of Diabetech, LP.

Pre-Conference Workshop: Monday, October 20, 2008 (1pm - 4pm)

Conference: Tuesday October 21 and October 22, 2008

Mobile Solutions and Strategies to Encourage Patient Self-Management to Improve Healthcare Delivery and Reduce Costs

Gaylord National Resort and Convention Center, National Harbor, MD, Washington, DC, United States

Meet Diabetech's President & CEO and learn how other healthcare practices have already implemented new technologies, new care models within their own practices and how they are successfully billing for patient encounters. Attendees at the workshop will leave understanding the various options and considerations available to them and will be better able to transform their own practice or regional centers for healthcare delivery within days of returning home. Includes Case Studies.

"It's quite advanced and very, very simple — even a child can do it. Patients experience better outcomes with less work and because of the ease of remote monitoring, my staff and I are able to provide timelier coaching which translates directly into fewer visits to the hospital." Dr. Stephen Ponder, medical director of the Children's Diabetes Center of South Texas at Driscoll

Complete release (pdf)

As the result of over 5 years of development in over a dozen clinical trials conducted throughout the USA, Diabetech is pleased to announce the direct-to-consumer commercial availability of the GlucoMON-RT subscription service for delivering real-time blood glucose alerts to remote caregivers as well as automated reporting. This program has proven to be especially valuable for families with children at school who must cope with the remote aspects of managing their children with type 1 diabetes. Children with 'type 1' require insulin and are always at high risk of severe complications. The blood sugar lowering effects of insulin also lead to seizure, coma and other serious life-threatening events. The GlucoMON-RT 'out-of-the-box' experience is the easiest way to collaborate with others who share in the management of an individual's diabetes.
Peace of mind for families and independence for the person with diabetes starts at $29.95/mo with no hardware to buy and no airtime contracts with the subscriber's existing cellular provider. For a limited time there is also a significantly discounted subscription for those who elect to prepay the first year of service. Orders for service including gift certificates may be placed online at http://mygluco.com or by contacting Diabetech toll free at 877.My.Gluco (877-694-5826). As part of the commercial launch, Diabetech is offering the 20/20 Plan (20 day trial for $20) and a referral program called "Get 3 Ride Free". For details, please contact Diabetech.

"The simplicity of the GlucoMON wireless device has made taking care of my 6 yr old son much easier with features like being able to view his blood glucose on my phone while he is at school", says Kerry Holcomb of Odessa,Texas and Mom to Cade. "It lets me make decisions and play a bigger role in his diabetes care without having to depend too much on his school or having to drive to school each day. The color-coded chart that I receive also saves me a lot of time in understanding his numbers. Being part of the Diabetech community is important to me, too, since I know they are working each day on new ways to make dealing with this disease easier".

The GlucoMON-RT subscription service is also useful for adult children with an elderly parent(s) who require additional oversight. Physicians, schools, churches, day care and assisted living centers, and nursing homes also benefit when consumers make the commitment to extend their diabetes self-care toolkit with GlucoMON-RT.

Download the Full Release (pdf)

Desert Dingo Racing announced today that GlucoMON has signed on as a
sponsor of the team's Baja 1000 race and for the 2008 race season. Desert Dingo Racing is campaigning the official World Diabetes Day car in the Baja 1000.

"We're excited to add the GlucoMON to our growing list of sponsors for the Official World Diabetes Day race car," said Desert Dingo Racing co-owner Jim Graham. "It shows what a great opportunity this race is for showcasing new diabetes devices at an international event such as the Baja 1000. The environment is harsh and any device that can take on the Baja can surely be counted on to function reliably in the classroom connecting kids with diabetes with their parents wherever they may be."

The GlucoMON isn't your average diabetes device. With embedded worldwide wireless network connectivity, the GlucoMON turns a standard glucose meter into a connected remote blood glucose monitoring system enabling 'GlucoMON Alerts' from children at school to their parent's cell phone as a text message or email as well as automated trend identification logbooks as part of a comprehensive Automated Diabetes Management System (ADMS).

"As part of the commercial pre-launch activities for the GlucoMON, we thought what better way to demonstrate the reliability of this device than to take on the desert in this grueling 3-day race across sand, through water and all the while taking more abuse than even the toughest kid could
ever dish out." said Kevin McMahon, President & CEO of Diabetech — manufacturer of the GlucoMON device.

The team's 1969 VW (No. 1146) will showcase the GlucoMON 'Baja Edition' on its dash and will sport the GlucoMON logo on its sides. The DDR team is available to discuss the value and importance of GlucoMON as a tool for families with type 1 diabetes to simply and automatically care for their children while at school, on sleepovers and any time their child is away from their side.

Desert Dingo Racing has also partnered with the International Diabetes Federation to conduct a drive-a-thon during the Baja 1000 to raise money for diabetes research and education. 100% of the funds raised go to the IDF to support its ongoing efforts.

Full press release as PDF

http://www.desertdingo.com

http://www.desertdingo.com/pr2.html

http://desertdingoracing.blogspot.com

Diabetech, LP, a pioneer and leader in the design & manufacture of
wireless devices and automated diabetes management systems (ADMS),
today announces the spin-off of its programs business into a new entity established as "healthcordia, llc".

The commercialization of Diabetech's research includes an emphasis on convenience, simplicity and accuracy. The healthcordia program lifecycle of 'measure, understand and act' was developed with input from behavioral psychologists, endocrinologists, patients and their caregivers. Outcomes data from the research shows that participants who are engaged in healthcordia's program lifecycle typically achieve reductions in average blood sugar (as measured by A1c) in excess of 1 full point. The HomeCheck
programs are designed to address the broad markets of wellness, diabetes and cardiovascular screening for individuals, payers, providers and researchers.

The first commercial programs from healthcordia include HomeCheck-A1c and HomeCheck-365 incorporating comprehensive blood composition analysis (hematology) and the world's most accurate A1c. HomeCheck is simple, private and secure. Only a small drop of blood is required via finger-stick and results are always within +/-0.1 of the True A1c. Accuracy is everything when you consider the effort that goes into self-management of diabetes. Research shows that A1c's obtained via benchtop analyzers in
the physician's office results in the patient receiving inaccurate feedback by more than +/-0.3 at least 16% of the time and by more than +/-0.5 at least 3% of the time**. Since A1c is for many patients the only source
of diagnostic self-care feedback, A1c to A1c comparison must be accurate and frequent. Other finger-stick methods have been documented to deliver even less accurate results. At a minimum, this lack of focus on
accurate feedback misinforms providers and demotivates the patient resulting in a lifetime of elevated blood sugars and corresponding complications.

HomeCheck-A1c delivers a convenient, cost effective and highly accurate tool for screening individuals and large groups for pre-diabetes, diabetes, heart attack risk and other conditions related to elevated blood sugar levels. The HomeCheck blood sample collection kit itself can be drop-shipped to the patient or utilized in physician's offices and the health fair setting. Blood samples are analyzed at healthcordia labs
with results reported electronically through the patient's secure personal health record.

HomeCheck-365 delivers a comprehensive annual management program incorporating HomeCheck A1c combined with education, scheduled encounters with remote Certified Diabetes Educators and an optional
participant incentive component.
Full HomeCheck A1c Release

** Source: Diabetes Care 30:135-137, 2007

Over 84% of the type 2 diabetes trial participants reduced their blood glucose levels as measured by a highly accurate hemoglobin A1c laboratory test by an average of 1.1 points; a significant improvement in blood sugar control.

As a speaker at ADA Scientific in the symposium entitled, "Beyond Health Care Practitioners – Diabetes Health Care Extenders", McMahon presented the data showing that twenty-six adult patients with type 2 diabetes participated in this 12 month study.

Following enrollment and establishment of the patient's profile, patient participants were given Diabetech's market leading GlucoMON® wireless glucose meter for automated and accurate blood glucose data
collection, automated GlucoDYNAMIX™ blood glucose logbooks from their online personal health record (PHR), QuickTips™ lifestyle and diabetes educational messages, HomeCheck™ hematology screening and
A1c laboratory tests at enrollment and every 90 days thereafter, activity guides and more. Minimal human intervention from program staff and practitioners in this trial also demonstrates the efficiencies gained
using automated technology instead of weekly phone calls from highly skilled professionals who are also in limited supply.
Diabetech® Presents Type 2 Diabetes
Clinical Trial Results at ADA Scientific Sessions (Full Release Pdf)

McMahon, who founded the company after his daughter was diagnosed with Type 1 diabetes, has discovered that the medical community places most of the responsibility for care with patients and often doesn’t take into account the need for other support. “That is the number one thing: You don’t manage it by yourself,” McMahon said. He added that traditionally, the driving force behind new technology has been reimbursement—either government or private—rather than patient needs. With the firsthand perspective of a family affected by diabetes, McMahon developed the GlucoMON as a means of promoting compliance.

Diabetech offers a better answer to patients and the healthcare industry when it comes to an effective model for diabetes care including control for spiralling costs. Diabetech’s GlucoMON blood glucose connectivity device ensures glucose meter accuracy and automates the collection and analysis of blood glucose data for use in the team management of diabetes. People typically report drops in their average blood glucose (haemoglobin A1c) levels from 10% - 30% when they use a GlucoMON and even more in
some cases.

GlucoMON®2 is approximately 80% smaller than the previous GlucoMON making it the smallest and lightest GlucoMON ever. GlucoMON2 also makes the world's easiest way to share blood glucose levels even easier with even more automation designed into the device itself. GlucoMON2 availability is planned for Q3 '2007 and is capable of operating anywhere in the world where there is support for GSM/GPRS networks.

GlucoMON®2 Wireless Glucose Meter